Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Oncopeptides AB

Closing information (x1000 EUR)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 751 More Arrow 11,567 Less Arrow 0
Financial expenses 79 More Arrow 93 More Arrow 148
Earnings before taxes -30,344 Less Arrow -138,984 Less Arrow -158,649
EBITDA -29,849 Less Arrow -136,850 Less Arrow -157,097
Total assets 34,626 More Arrow 42,963 More Arrow 94,322
Current assets 32,712 More Arrow 40,322 More Arrow 89,146
Current liabilities 7,474 More Arrow 22,025 More Arrow 30,605
Equity capital 26,445 Less Arrow 20,619 More Arrow 57,474
- share capital 942 Less Arrow 818 Less Arrow 616
Employees (average) 57 More Arrow 229 Less Arrow 182

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 76.4% Less Arrow 48.0% More Arrow 60.9%
Turnover per employee 13 More Arrow 51 Less Arrow 0
Profit as a percentage of turnover -4040.5% More Arrow -1201.6%
Return on assets (ROA) -87.4% Less Arrow -323.3% More Arrow -168.0%
Current ratio 437.7% Less Arrow 183.1% More Arrow 291.3%
Return on equity (ROE) -114.7% Less Arrow -674.1% More Arrow -276.0%
Change turnover -9,879 More Arrow 11,567 Less Arrow 0
Change turnover % -93%
Chg. No. of employees -172 More Arrow 47 More Arrow 145
Chg. No. of employees % -75% More Arrow 26% More Arrow 392%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.